Brandes Investment Partners 13F: Cuts Graham (GHM) Stake by $8.6M

Brandes Investment Partners has trimmed its position in GHM, reducing its holdings by 76,052 shares. This change, filed on May 15, 2026, with the SEC, brings Brandes' total GHM shares to 1,170,981, valued at approximately $132.8 million. The move represents a 6.1% decrease from their previous stake.

What Changed in Brandes Investment Partners' GHM Position

Brandes Investment Partners cut its GHM holdings by 76,052 shares, a 6.1% reduction. Previously holding 1,247,033 shares, the firm now owns 1,170,981 shares. The current value of this stake is around $132.8 million.

Other Institutional Activity in GHM

Other institutional investors have also adjusted their positions in GHM. BlackRock, Inc. reduced its stake by 10,376 shares, ending with 766,677 shares valued at approximately $60.5 million. Vanguard Capital Management LLC made a new investment, acquiring 453,812 shares worth about $35.8 million. Royce & Associates LP decreased its holdings by 23,449 shares, now holding 448,758 shares valued at $35.4 million. Driehaus Capital Management LLC trimmed 12,004 shares, leaving it with 342,908 shares valued at roughly $27.1 million. Meanwhile, William Blair Investment Management, LLC increased its position by 16,281 shares, bringing its total to 314,301 shares with a value of $24.8 million.

Graham Corporation Stock Up 59.5%

Shares of GHM are currently trading near $113.45. The company's market capitalization is approximately $132.8 million. The stock's 52-week range has not been provided, but the current trading price and market cap suggest a solid position in the market.

Insider Buying and Selling at Graham Corporation

Several insider transactions occurred on June 8, 2026. Executive Chairman Daniel Thoren sold 8,095 shares at an average price of $95.34. President and CEO Matthew Malone sold 2,477 shares at the same price, while also acquiring 8,619 shares at no cost. VP-Finance and CFO Christopher Thome sold 3,193 shares at $95.34 and bought 8,619 shares at no cost. Daniel Thoren also made a purchase of 22,101 shares at no cost.

Analysts Set New Price Targets

On June 9, 2026, Oppenheimer maintained its buy rating for GHM, setting a price target of $110. Earlier, on March 18, 2026, Oppenheimer had initiated coverage with a buy rating and a $100 target. The consensus among analysts is a buy rating, with a mean target price reflecting positive sentiment toward the stock.

About GHM

GHM operates in a sector that was not specified, but it is known for providing specialized products and services. The company is headquartered in an unspecified location, and it is led by a management team that includes President and CEO Matthew Malone.

Bottom Line

Brandes Investment Partners' decision to trim its GHM holdings is a notable change in its investment strategy. Investors often track such moves to gauge institutional sentiment, although it's important to remember that 13F filings are backward-looking and may not reflect current positions. GHM remains a stock of interest with active insider trading and positive analyst sentiment.